Clinical Updates in CSPC

 

Insights from 2023 ESMO Annual Meeting
A

ESMO 2023 Insights: "The BonEnza Study - Changes in Bone Mineral Density, Trabecular Bone Score, and Body Composition in mHSPC Patients Randomized to Receive ADT+Enzalutamide+/-Zoledronic Acid"

By Insights from 2023 ESMO Annual Meeting FEATURING Alberto Dalla Volta
By Insights from 2023 ESMO Annual Meeting FEATURING Alberto Dalla Volta
74 views
November 28, 2023
0 Comments
Login to view comments. Click here to Login
Clinical Updates in CSPC
11:07
PROSCA & BLADDR 2023

Treatment Intensification of High-Risk BCR Prostate Cancer

Feat. A. Rannikko
03:01
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Prognostic Role of Metastatic Site in Pati…

Feat. E. Yekedüz
09:02
Cedars Sinai

Year in Review: EMBARK Study and the Evolving Role of Intensified AD…

Feat. S. Freedland
09:51
Insights from 2023 Society of Urologic Oncology Annual Meeting

SUO 2023 Insights: "Doublets or Triplets for Patients With mCSP…

Feat. B. Maughan
09:19
Insights from 2023 European Multidisciplinary Congress on Urological Cancers

EMUC 2023 Insights: "De-Escalating Strategies in mHSPC - Who, W…

Feat. B. Tombal
05:29
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Real-World OS With Enzalutamide & Abir…

Feat. D. George
11:51
Joshua Lang

Therapeutic Approach in mCSPC: Doublets, Triplets, and Patient Selec…

08:35
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "The BonEnza Study - Changes in Bone Minera…

Feat. A. Dalla Volta
13:55
Total Health

Case-Based Clinical Updates in Prostate Cancer: 77 y/o Practicing Ph…

Feat. J. Zhang, J. Chadha, S. Raymond
18:17
International Urology Cancer Summit - IUCS

Treatment Landscape of mHSPC: Doublet or Triplet

Feat. N. Agarwal
20:24
Scripps MD Anderson Cancer Center

Metastatic Newly Diagnosed Prostate Cancer: Up-Front Intensification…

Feat. T. Barauskas Dorff
11:37
Insights from 2023 ASCO® Annual Meeting

Assessment and Decision Tools for Balancing Survival and Quality of …

Feat. E. Kessler
04:55
Yale Cancer Center

Post-Hoc Analyses of Phase 3 ARCHES Trial: OS in Patients With mHSPC…

Feat. D. Petrylak
42:54
Houston Methodist Hospital

30 Years Perspective on Advanced Prostate Cancer: Using Biology &…

Feat. M. Hussain
12:48
ASCO GU 2023 Conference Coverage

Cost-Effectiveness Analysis of Seven Treatment Regimens in mHSPC: A …

Feat. M. Kohli
15:51
Judd Moul

A Multidisciplinary Team Approach to Prostate Cancer

11:39
Oncology Data Advisor

Recent Prostate Cancer Updates

Feat. U. Vaishampayan
04:48
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "EMBARK Secondary Endpoints - Enzalutamide …

Feat. U. De Giorgi
10:12
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Phase 3 Randomized EMBARK Study - Enzaluta…

Feat. S. Freedland